Article Details
Retrieved on: 2021-08-18 14:47:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
At the time, the FDA also approved Roche's Ventana MMR RxDx immunohistochemistry panel as a companion diagnostic to select endometrial cancer ...
Article found on: www.precisiononcologynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here